scispace - formally typeset
M

Mark B. Orringer

Researcher at University of Michigan

Publications -  299
Citations -  28622

Mark B. Orringer is an academic researcher from University of Michigan. The author has contributed to research in topics: Esophagectomy & Esophagus. The author has an hindex of 81, co-authored 292 publications receiving 27081 citations. Previous affiliations of Mark B. Orringer include Johns Hopkins University & University of Toronto.

Papers
More filters
Journal ArticleDOI

Somatic mutations affect key pathways in lung adenocarcinoma

Li Ding, +96 more
- 23 Oct 2008 - 
TL;DR: Somatic mutations in primary lung adenocarcinoma for several tumour suppressor genes involved in other cancers and for sequence changes in PTPRD as well as the frequently deleted gene LRP1B are found.
Journal ArticleDOI

Gene-expression profiles predict survival of patients with lung adenocarcinoma

TL;DR: The identification of a set of genes that predict survival in early-stage lung adenocarcinoma allows delineation of a high-risk group that may benefit from adjuvant therapy.
Journal ArticleDOI

Randomized Trial of Preoperative Chemoradiation Versus Surgery Alone in Patients With Locoregional Esophageal Carcinoma

TL;DR: This randomized trial of preoperative chemoradiation versus surgery alone for patients with potentially resectable esophageal carcinoma did not demonstrate a statistically significant survival difference.
Journal ArticleDOI

Characterizing the cancer genome in lung adenocarcinoma

Barbara A. Weir, +85 more
- 06 Dec 2007 - 
TL;DR: A large-scale project to characterize copy-number alterations in primary lung adenocarcinomas using dense single nucleotide polymorphism arrays identifies NKX2-1 (NK2 homeobox 1, also called TITF1), which lies in the minimal 14q13.3 amplification interval and encodes a lineage-specific transcription factor, as a novel candidate proto-oncogene involved in a significant fraction of lung carcinomas.
Journal ArticleDOI

Discordant Protein and mRNA Expression in Lung Adenocarcinomas

TL;DR: The relationship between gene expression measured at the mRNA level and the corresponding protein level is not well characterized in human cancer, and it is shown that only a subset of the proteins exhibited a significant correlation with mRNA abundance.